logo
Twitter
Discord
Email
logo
Talkspace, Inc.

Talkspace, Inc.

NASDAQ•TALK
CEO: Dr. Jon R. Cohen M.D.
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2020-07-30
Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.
Contact Information
622 Third Avenue, New York, NY, 10017, United States
212-284-7206
www.talkspace.com
Market Cap
$549.29M
P/E (TTM)
130.2
32.6
Dividend Yield
--
52W High
$4.36
52W Low
$2.22
52W Range
50%
2.5
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 2.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2019-2024

Financial Dashboard

Q3 2025 Data

Revenue

$59.38M+25.28%
4-Quarter Trend

EPS

$0.02+76.58%
4-Quarter Trend

FCF

$1.90M-58.69%
4-Quarter Trend

2025 Q2 Earnings Highlights

Key Highlights

Revenue Growth Driven By Payor Total revenue reached $106.5M USD for six months ended June 30, 2025, marking a 16.4% increase year-over-year.
Significant Net Loss Improvement Net loss narrowed substantially to $223K USD for the six months, reflecting an 88.5% improvement compared to 2024.
Operating Loss Narrows Substantially Loss from operations improved by $2.3M USD, reaching $2.9M USD loss for the six months ended June 30, 2025.

Risk Factors

Cost of Revenue Rising Faster Cost of revenue increased 22.9% to $59.7M USD for six months, driven by increased therapist hours and sessions.
Consumer Revenue Declining Sharply Consumer revenue fell 32.0% to $9.2M USD for six months due to strategic focus shift away from direct subscribers.
Cash Used in Operations Net cash used in operating activities totaled $1.6M USD for the six months ended June 30, 2025, reversing prior year inflow.

Outlook

Strong Liquidity Position Maintained Ended period with $54.3M USD cash and equivalents; company confirms no short-term or long-term debt obligations exist.
Strategic Focus on Payor Growth Strategy centers on optimizing marketing efforts to attract Payor members, evidenced by 34.0% Payor revenue growth.
Share Repurchase Availability $20.6M USD remains authorized for common stock repurchases under the existing Share Repurchase Program as of June 30.

Peer Comparison

Revenue (TTM)

Community Health Systems, Inc.CYH
$12.64B
+0.7%
agilon health, inc.AGL
$5.90B
+10.1%
Cross Country Healthcare, Inc.CCRN
$1.19B
-24.3%

Gross Margin (Latest Quarter)

Rigel Pharmaceuticals, Inc.RIGL
95.6%
+3.2 pp
Community Health Systems, Inc.CYH
56.0%
+15.2 pp
Avanos Medical, Inc.AVNS
52.6%
-3.0 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
PACB$672.83M-1.3-189.2%84.7%
RIGL$549.78M5.6438.9%29.5%
TALK$549.29M130.23.7%0.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
+6.8%
Steady Growth
4Q Net Income CAGR
+38.9%
Profitability Improved
Cash Flow Stability
50%
Cash Flow Needs Attention

Research & Insights

Reports
All Years

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 8, 2025|
    Revenue: $54.31M+17.9%
    |
    EPS: $-0.00+14.3%
    Miss

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 9, 2025|
    Revenue: $52.18M+14.9%
    |
    EPS: $0.00-121.9%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 12, 2025|
    Revenue: $187.59M+25.0%
    |
    EPS: $0.01+105.7%
    Miss

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $47.40M+22.6%
    |
    EPS: $0.01-141.9%
    Beat

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 8, 2024|
    Revenue: $46.06M+29.2%
    |
    EPS: $-0.00-90.2%
    Miss

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 9, 2024|
    Revenue: $45.42M+36.2%
    |
    EPS: $-0.01-84.0%
    Miss

  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Mar 13, 2024|
    Revenue: $150.05M+25.5%
    |
    EPS: $-0.00+80.0%
    Beat

  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Nov 7, 2023|
    Revenue: $38.65M+31.8%
    |
    EPS: $-0.03+26400.0%
    Beat